Skip Navigation LinksHome > November 25, 2013 - Volume 35 - Issue 22 > FDA Grants 510(k) Clearance for Digital HER2 Status Test
Oncology Times:
doi: 10.1097/01.COT.0000438520.95596.f4
News

FDA Grants 510(k) Clearance for Digital HER2 Status Test

Free Access

The U.S. Food and Drug Administration has granted 510(k) clearance to Her2/neu IHC Digital Manual Read (Philips), a digital system to assess HER2 status in breast cancer patients to help determine treatment options. The 510(k) allows for the device to be marketed in the U.S., and demonstrates the device is safe and effective.

Figure
Image Tools

Her2/neu IHC Digital Manual Read is an automated digital slide creation system. It allows pathologists to use digitally stored Her2/neu IHC images to help them in the detection and semi-quantitative measurement of immunohistochemically (IHC) stained breast cancer tissue on their computer monitor.

The system was previously commercially introduced in Europe and Asia Pacific in 2012.

Wolters Kluwer Health | Lippincott Williams & Wilkins

Login

Article Tools

Images

Share